DPI-221

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

DPI-221 is a drug which is used in scientific research. It is a highly selective agonist for the δ-opioid receptor which produces less convulsions than most drugs from this family.^[1]

References

↑ Holt JD, Watson MJ, Chang JP, O’Neill SJ, Wei K, Pendergast W, Gengo PJ, Chang KJ. DPI-221 [4-((alpha-s)-alpha-((2s,5r)-2,5-dimethyl-4-(3-fluorobenzyl)-1-piperazinyl)benzyl)-N,N-diethylbenzamide]: a novel nonpeptide delta receptor agonist producing increased micturition interval in normal rats. Journal of Pharmacology and Experimental Therapeutics. 2005 Nov;315(2):601-8. PMID 16020629

Template:Opioids

Template:WikiDoc Sources

[1] Holt JD, Watson MJ, Chang JP, O’Neill SJ, Wei K, Pendergast W, Gengo PJ, Chang KJ. DPI-221 [4-((alpha-s)-alpha-((2s,5r)-2,5-dimethyl-4-(3-fluorobenzyl)-1-piperazinyl)benzyl)-N,N-diethylbenzamide]: a novel nonpeptide delta receptor agonist producing increased micturition interval in normal rats. Journal of Pharmacology and Experimental Therapeutics. 2005 Nov;315(2):601-8. PMID 16020629

[1]